Louis J. Lavigne
Louis J. Lavigne Jr. has been a director of Novocure since 2012 and has served as the chairperson of our audit committee since 2012. Mr. Lavigne is currently the Managing Director of Lavrite, LLC, a management consulting firm specializing in corporate finance, accounting, growth strategy and management, and is also the managing member of Spring Development Group, LLC, a specialized investor in growth situations. Mr. Lavigne retired in March 2005 as Executive Vice President and Chief Financial Officer of Genentech, Inc., where he had served in roles of increasing responsibility since 1982. He currently serves on the boards of Accuray, Inc., Depomed, Inc., DocuSign, Inc., Zynga, Inc., Rodan & Fields, LLC, and Puppet, Inc. Mr. Lavigne also previously served on the boards of Allergan, Inc., BMC Software, Inc., and SafeNet, Inc. Mr. Lavigne is a member and former chairman of the UCSF Benioff Children’s Hospitals Board of Directors and the UCSF Benioff Children’s Hospitals Foundation. Mr. Lavigne earned a B.S. in business administration from Babson College and an M.B.A. from Temple University.